Mariner’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-8,433
Closed -$520K 3754
2025
Q4
$520K Buy
8,433
+3,107
+58% +$190K ﹤0.01% 2421
2025
Q3
$332K Sell
5,326
-473
-8% -$32.9K ﹤0.01% 2728
2025
Q2
$463K Buy
5,799
+429
+8% +$35.9K ﹤0.01% 2390
2025
Q1
$462K Sell
5,370
-122
-2% -$10K ﹤0.01% 2267
2024
Q4
$429K Buy
5,492
+615
+13% +$47.7K ﹤0.01% 2310
2024
Q3
$351K Buy
4,877
+244
+5% +$17.3K ﹤0.01% 2435
2024
Q2
$319K Sell
4,633
-82
-2% -$5.55K ﹤0.01% 2402
2024
Q1
$342K Sell
4,715
-145
-3% -$9.7K ﹤0.01% 2327
2023
Q4
$298K Buy
+4,860
New +$289K ﹤0.01% 2365

Other funds holding PBH

Mariner's PBH Position: Q1 2026 in Review

Mariner sold out of Prestige Consumer Healthcare (PBH) in Q1 2026, closing a stake of 8,433 shares — an estimated $520K sold.

Mariner first reported a position in PBH in Q4 2023 and held it in 9 quarters. The position peaked at $520K in Q4 2025. 355 funds tracked by Wall St. Rank hold PBH as of Q1 2026.

  • Mariner reported no remaining Prestige Consumer Healthcare position as of Q1 2026 after selling out during the quarter.
  • Mariner sold 8,433 Prestige Consumer Healthcare shares in Q1 2026, an estimated $520K.
  • Mariner first reported a position in Prestige Consumer Healthcare in Q4 2023 and held it in 9 quarters.
  • Mariner's Prestige Consumer Healthcare position peaked at $520K in Q4 2025.
  • 355 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q1 2026.

Based on Mariner's 13F filing for Q1 2026, filed 13 May 2026.